Byrne Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$354K Hold
977
0.19% 90
2026
Q1
$344K Sell
977
-11
-1% -$3.92K 0.2% 92
2025
Q4
$323K Sell
988
-9
-0.9% -$2.85K 0.18% 97
2025
Q3
$281K Buy
+997
New +$289K 0.17% 95
2025
Q2
Sell
-1,133
Closed -$321K 88
2025
Q1
$353K Sell
1,133
-68
-6% -$20.1K 0.26% 79
2024
Q4
$313K Sell
1,201
-25
-2% -$7.42K 0.22% 84
2024
Q3
$395K Sell
1,226
-66
-5% -$21.6K 0.27% 78
2024
Q2
$405K Buy
+1,292
New +$380K 0.29% 78
2024
Q1
Sell
-1,518
Closed -$444K 81
2023
Q4
$435K Buy
+1,518
New +$414K 0.33% 76
2023
Q3
Sell
-1,516
Closed -$378K 73
2023
Q2
$337K Buy
1,516
+350
+30% +$81.2K 0.22% 114
2023
Q1
$282K Buy
1,166
+215
+23% +$52.8K 0.2% 116
2022
Q4
$250K Sell
951
-114
-11% -$30.6K 0.18% 119
2022
Q3
$240K Buy
1,065
+19
+2% +$4.61K 0.19% 107
2022
Q2
$254K Buy
1,046
+254
+32% +$62.2K 0.19% 94
2022
Q1
$192K Buy
792
+20
+3% +$4.59K 0.12% 113
2021
Q4
$174K Buy
+772
New +$163K 0.11% 117

Other funds holding AMGN

Byrne Asset Management's AMGN Position: Q2 2026 in Review

Byrne Asset Management held its Amgen (AMGN) position steady in Q2 2026 at 977 shares worth $354K. The position accounts for 0.19% of the portfolio, ranked #90.

Byrne Asset Management first reported a position in AMGN in Q4 2021 and has held it in 16 quarters since. The position peaked at $435K in Q4 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Byrne Asset Management held 977 shares of Amgen worth $354K as of Q2 2026.
  • Byrne Asset Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.19% of Byrne Asset Management's portfolio in Q2 2026, its #90 holding.
  • Byrne Asset Management first reported a position in Amgen in Q4 2021 and has held it in 16 quarters since.
  • Byrne Asset Management's Amgen position peaked at $435K in Q4 2023.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.